FAMOTIDINE

FAMOTIDINE was reported 120124 times

FAMOTIDINE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 241 0.2269
1 NEPHROGENIC ANAEMIA 880 0.1898
2 REBOUND ACID HYPERSECRETION 552 0.1823
3 HYPERPARATHYROIDISM SECONDARY 441 0.1758
4 MAST CELL ACTIVATION SYNDROME 200 0.1425
5 END STAGE RENAL DISEASE 2012 0.1102
6 CHRONIC KIDNEY DISEASE 6672 0.0877
7 INFUSION SITE DISCHARGE 135 0.0769
8 ACCIDENTAL DRUG INTAKE BY CHILD 96 0.0625
9 APLASTIC ANAEMIA 307 0.0587
10 CALCIUM DEFICIENCY 74 0.0571
11 ESSENTIAL HYPERTENSION 95 0.0519
12 RENAL INJURY 1499 0.0504
13 INFUSION SITE HAEMORRHAGE 162 0.0492
14 INFUSION SITE SWELLING 287 0.0456
15 INFUSION SITE PRURITUS 135 0.0427
16 TUBULOINTERSTITIAL NEPHRITIS 748 0.0399
17 INFUSION SITE BRUISING 86 0.0398
18 DEVICE INFUSION ISSUE 96 0.0387
19 INFUSION SITE PAIN 493 0.0382
20 INFUSION SITE ERYTHEMA 322 0.0382
21 GASTROINTESTINAL HYPOMOTILITY 84 0.0372
22 INFUSION SITE INFECTION 83 0.0357
23 IMPAIRED GASTRIC EMPTYING 448 0.0328
24 GASTROOESOPHAGEAL REFLUX DISEASE 2587 0.0321
25 RHINOVIRUS INFECTION 124 0.0318
26 RENAL FAILURE 4127 0.0310
27 ACUTE KIDNEY INJURY 4747 0.0310
28 PEPTIC ULCER 101 0.0304
29 NEPHROPATHY 283 0.0303
30 HYPERVOLAEMIA 148 0.0299
31 SEASONAL ALLERGY 416 0.0294
32 INFUSION SITE REACTION 84 0.0281
33 ATELECTASIS 271 0.0280
34 MONOCYTE COUNT INCREASED 100 0.0275
35 VITAMIN B12 DEFICIENCY 109 0.0269
36 VITAMIN D DEFICIENCY 262 0.0268
37 PRODUCT ADMINISTRATION INTERRUPTED 209 0.0266
38 CHOLECYSTITIS CHRONIC 176 0.0263
39 VASCULAR DEVICE INFECTION 118 0.0260
40 RENAL TUBULAR NECROSIS 255 0.0260
41 METABOLIC ENCEPHALOPATHY 78 0.0260
42 ACUTE RESPIRATORY FAILURE 493 0.0256
43 CHOLECYSTITIS ACUTE 145 0.0256
44 PHARYNGEAL SWELLING 246 0.0251
45 TYPE I HYPERSENSITIVITY 87 0.0247
46 BLOOD MAGNESIUM DECREASED 209 0.0242
47 INTERVERTEBRAL DISC DEGENERATION 220 0.0238
48 SPINAL OSTEOARTHRITIS 206 0.0234
49 PROTEIN TOTAL DECREASED 88 0.0233
50 DISSEMINATED INTRAVASCULAR COAGULATION 328 0.0233
51 HAEMOGLOBIN INCREASED 105 0.0230
52 DIVERTICULUM INTESTINAL 100 0.0228
53 BONE LESION 82 0.0227
54 BLOOD ALBUMIN DECREASED 175 0.0220
55 BLOOD LACTATE DEHYDROGENASE INCREASED 342 0.0216
56 DERMATITIS CONTACT 246 0.0215
57 RHINITIS ALLERGIC 96 0.0215
58 OSTEOPENIA 323 0.0213
59 LEFT VENTRICULAR HYPERTROPHY 91 0.0212
60 BLOOD UREA INCREASED 356 0.0212
61 HYPOVOLAEMIA 124 0.0212
62 BRAIN FOG 332 0.0212
63 MOUTH HAEMORRHAGE 155 0.0211
64 FOOD ALLERGY 163 0.0211
65 HYPOPHOSPHATAEMIA 156 0.0211
66 ECONOMIC PROBLEM 318 0.0210
67 STAPHYLOCOCCAL BACTERAEMIA 91 0.0209
68 AORTIC VALVE INCOMPETENCE 89 0.0209
69 HYPOMAGNESAEMIA 287 0.0206
70 HAEMATOCRIT DECREASED 406 0.0205
71 PERIORBITAL SWELLING 115 0.0203
72 HIATUS HERNIA 262 0.0202
73 HEREDITARY ANGIOEDEMA 217 0.0202
74 HYPERURICAEMIA 83 0.0202
75 TRICUSPID VALVE INCOMPETENCE 160 0.0201
76 ANAPHYLACTIC REACTION 1101 0.0199
77 HOSPICE CARE 196 0.0198
78 MULTIPLE ALLERGIES 155 0.0198
79 ENTEROCOLITIS 114 0.0197
80 DYSPEPSIA 1938 0.0197
81 HYPOALBUMINAEMIA 153 0.0197
82 GASTRITIS 515 0.0196
83 RED CELL DISTRIBUTION WIDTH INCREASED 81 0.0195
84 CYTOKINE RELEASE SYNDROME 386 0.0192
85 PHYSICAL DISABILITY 85 0.0192
86 EPIGASTRIC DISCOMFORT 75 0.0192
87 IMPAIRED QUALITY OF LIFE 276 0.0192
88 CLOSTRIDIUM DIFFICILE COLITIS 203 0.0191
89 FEBRILE NEUTROPENIA 1263 0.0190
90 HYPERLIPIDAEMIA 227 0.0190
91 BLOOD PRESSURE SYSTOLIC DECREASED 86 0.0189
92 RENAL FAILURE CHRONIC 145 0.0188
93 WEIGHT FLUCTUATION 197 0.0188
94 HYPOXIA 657 0.0186
95 POST-TRAUMATIC STRESS DISORDER 125 0.0186
96 SYNOVIAL CYST 86 0.0186
97 ANHEDONIA 486 0.0185
98 UPPER-AIRWAY COUGH SYNDROME 151 0.0183
99 HEPATIC FUNCTION ABNORMAL 679 0.0182
100 BLOOD URIC ACID INCREASED 105 0.0182
101 ASPARTATE AMINOTRANSFERASE INCREASED 965 0.0181
102 KIDNEY TRANSPLANT REJECTION 87 0.0181
103 MALNUTRITION 201 0.0179
104 COMPRESSION FRACTURE 96 0.0179
105 RENAL CYST 142 0.0179
106 PRE-EXISTING CONDITION IMPROVED 111 0.0178
107 FAILURE TO THRIVE 92 0.0177
108 MITRAL VALVE INCOMPETENCE 200 0.0177
109 INCORRECT DRUG ADMINISTRATION RATE 75 0.0176
110 BLOOD ALKALINE PHOSPHATASE INCREASED 435 0.0175
111 INFUSION RELATED REACTION 1160 0.0175
112 DIVERTICULUM 124 0.0174
113 LUNG INFILTRATION 154 0.0174
114 PNEUMONIA BACTERIAL 160 0.0174
115 PATHOLOGICAL FRACTURE 88 0.0173
116 DECUBITUS ULCER 140 0.0172
117 RESPIRATORY SYNCYTIAL VIRUS INFECTION 149 0.0171
118 BLOOD POTASSIUM DECREASED 513 0.0170
119 DIABETIC NEUROPATHY 84 0.0169
120 SPINAL COMPRESSION FRACTURE 140 0.0169
121 MUCOSAL INFLAMMATION 443 0.0169
122 CARDIOMEGALY 208 0.0169
123 RED BLOOD CELL COUNT DECREASED 482 0.0168
124 PERIPHERAL VASCULAR DISORDER 86 0.0167
125 IRON DEFICIENCY ANAEMIA 154 0.0167
126 MENTAL STATUS CHANGES 461 0.0166
127 ALANINE AMINOTRANSFERASE INCREASED 1018 0.0166
128 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 90 0.0165
129 SMALL INTESTINAL OBSTRUCTION 203 0.0165
130 OSTEOPOROSIS 676 0.0164
131 PULMONARY HYPERTENSION 342 0.0164
132 STAPHYLOCOCCAL SEPSIS 81 0.0164
133 OROPHARYNGEAL DISCOMFORT 147 0.0163
134 URINE OUTPUT DECREASED 142 0.0162
135 INSURANCE ISSUE 248 0.0162
136 SINUS TACHYCARDIA 230 0.0162
137 UPPER RESPIRATORY TRACT INFECTION 743 0.0161
138 PNEUMOTHORAX 254 0.0160
139 OXYGEN SATURATION DECREASED 896 0.0159
140 MULTIPLE MYELOMA 74 0.0159
141 PLATELET COUNT DECREASED 1689 0.0158
142 COVID-19 PNEUMONIA 187 0.0158
143 BLOOD SODIUM DECREASED 298 0.0158
144 HYPERKERATOSIS 87 0.0158
145 SCOLIOSIS 97 0.0156
146 ILEUS 194 0.0156
147 VENTRICULAR TACHYCARDIA 257 0.0155
148 LYMPHOCYTE COUNT DECREASED 275 0.0155
149 TORSADE DE POINTES 122 0.0155
150 ANGINA UNSTABLE 101 0.0155
151 NEUTROPHIL COUNT DECREASED 633 0.0155
152 POLYP 101 0.0154
153 BONE DISORDER 281 0.0154
154 THROAT TIGHTNESS 417 0.0154
155 PROTHROMBIN TIME PROLONGED 92 0.0154
156 PNEUMONIA ASPIRATION 384 0.0154
157 TASTE DISORDER 311 0.0153
158 PSYCHOLOGICAL TRAUMA 132 0.0153
159 ORAL CANDIDIASIS 201 0.0152
160 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 77 0.0152
161 SLEEP APNOEA SYNDROME 289 0.0151
162 HYPOKALAEMIA 697 0.0151
163 DIZZINESS POSTURAL 146 0.0150
164 BACTERAEMIA 178 0.0150
165 GALLBLADDER DISORDER 266 0.0149
166 ABDOMINAL TENDERNESS 74 0.0149
167 ARTERIOSCLEROSIS 140 0.0149
168 NERVE COMPRESSION 137 0.0148
169 FLANK PAIN 139 0.0148
170 THROAT IRRITATION 665 0.0148
171 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 152 0.0148
172 APPETITE DISORDER 98 0.0148
173 GASTROINTESTINAL MOTILITY DISORDER 79 0.0147
174 OESOPHAGITIS 161 0.0147
175 DYSPNOEA EXERTIONAL 553 0.0147
176 MUSCULOSKELETAL CHEST PAIN 227 0.0147
177 HYPERCHLORHYDRIA 86 0.0146
178 WHITE BLOOD CELL COUNT INCREASED 560 0.0146
179 DECREASED ACTIVITY 157 0.0145
180 HEART RATE ABNORMAL 81 0.0145
181 NOCTURIA 176 0.0145
182 GASTRIC ULCER 275 0.0145
183 CYSTIC FIBROSIS 80 0.0144
184 SKIN LACERATION 157 0.0144
185 HYDRONEPHROSIS 108 0.0144
186 SUPRAVENTRICULAR TACHYCARDIA 138 0.0144
187 FAECES DISCOLOURED 312 0.0144
188 MULTIPLE FRACTURES 236 0.0144
189 TUMOUR LYSIS SYNDROME 126 0.0143
190 BLOOD CALCIUM DECREASED 161 0.0143
191 CHOLECYSTITIS 170 0.0143
192 FOOT FRACTURE 270 0.0142
193 INCREASED TENDENCY TO BRUISE 131 0.0142
194 FAECALOMA 78 0.0142
195 BLOOD BILIRUBIN INCREASED 383 0.0142
196 MULTI-ORGAN FAILURE 245 0.0142
197 BLOOD IRON DECREASED 168 0.0141
198 CHOLELITHIASIS 463 0.0141
199 BLOOD POTASSIUM INCREASED 229 0.0141
200 LEUKOCYTOSIS 255 0.0141
201 PLEURAL EFFUSION 855 0.0140
202 HICCUPS 115 0.0140
203 DEHYDRATION 1867 0.0140
204 INFUSION SITE EXTRAVASATION 87 0.0140
205 ANOREXIA 180 0.0140
206 ELECTROLYTE IMBALANCE 162 0.0139
207 TRANSFUSION 146 0.0139
208 CONCOMITANT DISEASE AGGRAVATED 86 0.0139
209 RESPIRATION ABNORMAL 96 0.0139
210 ATRIAL FLUTTER 111 0.0139
211 GASTROENTERITIS 203 0.0139
212 EMPHYSEMA 140 0.0139
213 VITAMIN D DECREASED 118 0.0138
214 ERUCTATION 267 0.0138
215 WHITE BLOOD CELL COUNT ABNORMAL 88 0.0138
216 CONSTIPATION 3006 0.0138
217 RESPIRATORY FAILURE 1002 0.0137
218 ACIDOSIS 105 0.0137
219 ROTATOR CUFF SYNDROME 176 0.0137
220 RENAL IMPAIRMENT 1148 0.0137
221 LIGAMENT SPRAIN 135 0.0136
222 PRODUCT DOSE OMISSION IN ERROR 385 0.0136
223 VENTRICULAR EXTRASYSTOLES 141 0.0136
224 POOR VENOUS ACCESS 140 0.0135
225 CHEST DISCOMFORT 1380 0.0135
226 CELLULITIS 679 0.0135
227 OSTEOARTHRITIS 571 0.0135
228 EOSINOPHIL COUNT INCREASED 112 0.0134
229 INTERSTITIAL LUNG DISEASE 650 0.0134
230 FLATULENCE 761 0.0134
231 ECCHYMOSIS 92 0.0134
232 BLOOD PRESSURE DIASTOLIC DECREASED 99 0.0134
233 URINARY TRACT INFECTION 2283 0.0134
234 NEUTROPHIL COUNT INCREASED 137 0.0134
235 PAIN IN JAW 379 0.0134
236 MOUTH SWELLING 77 0.0133
237 HAEMORRHOIDS 260 0.0133
238 PSEUDOMONAS INFECTION 114 0.0133
239 DRUG SCREEN POSITIVE 105 0.0133
240 CLOSTRIDIUM DIFFICILE INFECTION 290 0.0133
241 BLOOD CREATININE INCREASED 866 0.0133
242 RALES 77 0.0132
243 GENERALISED OEDEMA 164 0.0132
244 ANAL INCONTINENCE 119 0.0132
245 ENCEPHALOPATHY 324 0.0132
246 COLITIS ISCHAEMIC 89 0.0132
247 SEPSIS 1468 0.0131
248 HAEMOGLOBIN DECREASED 1350 0.0131
249 CARPAL TUNNEL SYNDROME 184 0.0131
250 RIGHT VENTRICULAR FAILURE 92 0.0131
251 HAND FRACTURE 93 0.0131
252 HAIR COLOUR CHANGES 163 0.0131
253 HAEMOPTYSIS 364 0.0130
254 MUSCULOSKELETAL DISCOMFORT 224 0.0130
255 ELECTROCARDIOGRAM ABNORMAL 102 0.0130
256 DRY THROAT 132 0.0130
257 DERMATITIS ACNEIFORM 79 0.0130
258 HAEMODIALYSIS 109 0.0130
259 BLOOD PRESSURE ABNORMAL 258 0.0130
260 ARTHROPOD BITE 96 0.0129
261 TENDERNESS 135 0.0129
262 THERAPEUTIC RESPONSE UNEXPECTED 580 0.0129
263 SINUS DISORDER 255 0.0129
264 ORAL PAIN 288 0.0128
265 ARTERIOSCLEROSIS CORONARY ARTERY 85 0.0128
266 WHITE BLOOD CELL COUNT DECREASED 1385 0.0128
267 TROPONIN INCREASED 97 0.0127
268 LIVER DISORDER 565 0.0127
269 WALKING AID USER 84 0.0127
270 PRODUCTIVE COUGH 608 0.0127
271 HEPATIC STEATOSIS 237 0.0127
272 LOWER GASTROINTESTINAL HAEMORRHAGE 94 0.0127
273 GASTROENTERITIS VIRAL 229 0.0127
274 RETCHING 270 0.0127
275 NASAL CONGESTION 744 0.0126
276 FLUSHING 1282 0.0126
277 FULL BLOOD COUNT DECREASED 254 0.0126
278 PROCTALGIA 81 0.0126
279 RIB FRACTURE 259 0.0126
280 BRONCHITIS 931 0.0126
281 SPLENOMEGALY 147 0.0125
282 ASPIRATION 137 0.0125
283 PRODUCT DISTRIBUTION ISSUE 116 0.0125
284 PULMONARY MASS 186 0.0125
285 CORONARY ARTERY OCCLUSION 171 0.0125
286 LIP SWELLING 415 0.0124
287 MAJOR DEPRESSION 91 0.0124
288 INTENTIONAL DOSE OMISSION 355 0.0124
289 TOXIC EPIDERMAL NECROLYSIS 189 0.0124
290 ATRIOVENTRICULAR BLOCK COMPLETE 83 0.0124
291 ODYNOPHAGIA 74 0.0124
292 MENISCUS INJURY 76 0.0123
293 INTERVERTEBRAL DISC PROTRUSION 270 0.0123
294 CORONARY ARTERY DISEASE 373 0.0123
295 VIRAL INFECTION 409 0.0123
296 POSTOPERATIVE WOUND INFECTION 83 0.0123
297 EAR INFECTION 327 0.0123
298 PARAESTHESIA ORAL 177 0.0123
299 ORAL DISCOMFORT 170 0.0122
300 TEMPERATURE INTOLERANCE 126 0.0122
301 ADRENAL INSUFFICIENCY 148 0.0122
302 RENAL FAILURE ACUTE 517 0.0122
303 STOMATITIS 738 0.0122
304 CARDIAC FAILURE ACUTE 81 0.0121
305 COVID-19 2133 0.0121
306 ULCER 193 0.0121
307 ACUTE RESPIRATORY DISTRESS SYNDROME 214 0.0121
308 RESPIRATORY TRACT CONGESTION 192 0.0121
309 ILLNESS 1241 0.0120
310 SWOLLEN TONGUE 376 0.0120
311 EAR PAIN 234 0.0120
312 HYPERKALAEMIA 422 0.0120
313 UROSEPSIS 111 0.0120
314 RESPIRATORY DISTRESS 332 0.0120
315 DECREASED APPETITE 2791 0.0120
316 BLOOD PRESSURE DECREASED 797 0.0120
317 URTICARIA 2009 0.0120
318 GINGIVAL PAIN 95 0.0119
319 EPISTAXIS 892 0.0119
320 PULMONARY OEDEMA 534 0.0119
321 RESPIRATORY TRACT INFECTION 310 0.0119
322 SINUS BRADYCARDIA 115 0.0119
323 TONGUE DISORDER 86 0.0119
324 ABDOMINAL DISTENSION 1238 0.0118
325 ATRIAL FIBRILLATION 1152 0.0118
326 INCONTINENCE 125 0.0118
327 HYPOPHAGIA 302 0.0118
328 ERYTHEMA MULTIFORME 110 0.0118
329 POST PROCEDURAL COMPLICATION 226 0.0118
330 MYASTHENIA GRAVIS 95 0.0118
331 IRRITABLE BOWEL SYNDROME 252 0.0117
332 COUGH 3295 0.0117
333 SINUSITIS 1204 0.0117
334 SENSATION OF FOREIGN BODY 99 0.0117
335 CEREBRAL INFARCTION 287 0.0117
336 DYSPHAGIA 1111 0.0117
337 GOUT 210 0.0117
338 SINUS CONGESTION 158 0.0117
339 FAECES SOFT 85 0.0117
340 CYSTITIS 371 0.0116
341 CHEST PAIN 2154 0.0116
342 EYE PAIN 656 0.0116
343 PNEUMONIA 3761 0.0116
344 PNEUMONITIS 316 0.0116
345 CARDIAC FLUTTER 75 0.0116
346 SPUTUM DISCOLOURED 110 0.0116
347 NEURALGIA 282 0.0116
348 NECK PAIN 648 0.0116
349 ABDOMINAL PAIN UPPER 2386 0.0116
350 FEEDING DISORDER 235 0.0116
351 INTERNAL HAEMORRHAGE 132 0.0115
352 UPPER GASTROINTESTINAL HAEMORRHAGE 194 0.0115
353 WRIST FRACTURE 138 0.0115
354 ANKLE FRACTURE 178 0.0115
355 DEVICE RELATED INFECTION 177 0.0115
356 OCULAR DISCOMFORT 129 0.0115
357 ASCITES 337 0.0115
358 DRUG ERUPTION 203 0.0114
359 OSTEOMYELITIS 207 0.0114
360 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 596 0.0114
361 TACHYPNOEA 155 0.0114
362 EAR DISCOMFORT 117 0.0114
363 COLITIS 432 0.0114
364 MICTURITION URGENCY 130 0.0114
365 GASTROINTESTINAL INFECTION 102 0.0114
366 RESPIRATORY RATE INCREASED 101 0.0114
367 PANCYTOPENIA 634 0.0113
368 NEUROPATHY PERIPHERAL 1079 0.0113
369 CARDIAC MURMUR 98 0.0113
370 DYSPHONIA 662 0.0113
371 BODY HEIGHT DECREASED 121 0.0113
372 NEPHROLITHIASIS 519 0.0113
373 SPINAL DISORDER 107 0.0113
374 EXPOSURE DURING PREGNANCY 701 0.0113
375 RESTLESS LEGS SYNDROME 205 0.0113
376 FLUID OVERLOAD 164 0.0113
377 HEART RATE INCREASED 1116 0.0113
378 GRAFT VERSUS HOST DISEASE 81 0.0113
379 ABDOMINAL DISCOMFORT 1888 0.0112
380 QUALITY OF LIFE DECREASED 151 0.0112
381 ANAEMIA 2144 0.0112
382 GAMMA-GLUTAMYLTRANSFERASE INCREASED 249 0.0112
383 BACK PAIN 2610 0.0112
384 LARGE INTESTINE PERFORATION 78 0.0112
385 DIARRHOEA 7249 0.0112
386 OEDEMA 609 0.0112
387 HYPOCALCAEMIA 212 0.0112
388 HYPERBILIRUBINAEMIA 116 0.0112
389 TOOTH ABSCESS 114 0.0112
390 HAIR DISORDER 92 0.0112
391 VENTRICULAR FIBRILLATION 124 0.0112
392 UNRESPONSIVE TO STIMULI 288 0.0111
393 PULMONARY CONGESTION 147 0.0111
394 LYMPHOEDEMA 77 0.0111
395 EATING DISORDER 237 0.0111
396 COAGULOPATHY 185 0.0111
397 BOWEL MOVEMENT IRREGULARITY 85 0.0111
398 TOOTH INFECTION 146 0.0111
399 GLOMERULAR FILTRATION RATE DECREASED 136 0.0111
400 PLATELET COUNT INCREASED 144 0.0110
401 DRY EYE 551 0.0110
402 BACK INJURY 120 0.0110
403 SECRETION DISCHARGE 138 0.0110
404 BACTERIAL INFECTION 205 0.0110
405 HYPERCHOLESTEROLAEMIA 106 0.0110
406 LARGE INTESTINE POLYP 76 0.0110
407 EMBOLISM 91 0.0109
408 DENTAL CARIES 121 0.0109
409 HYPONATRAEMIA 615 0.0109
410 SEPTIC SHOCK 475 0.0109
411 SARS-COV-2 TEST POSITIVE 144 0.0109
412 DIVERTICULITIS 302 0.0109
413 SUBARACHNOID HAEMORRHAGE 111 0.0109
414 TACHYCARDIA 968 0.0109
415 RHINORRHOEA 701 0.0108
416 HYPERSOMNIA 310 0.0108
417 CHILLS 1267 0.0108
418 OROPHARYNGEAL PAIN 1000 0.0108
419 SKIN ULCER 279 0.0108
420 VITREOUS FLOATERS 106 0.0108
421 BIPOLAR DISORDER 117 0.0108
422 RENAL DISORDER 501 0.0107
423 LIMB INJURY 292 0.0107
424 GASTROINTESTINAL PAIN 118 0.0107
425 CANDIDA INFECTION 181 0.0107
426 INCORRECT PRODUCT ADMINISTRATION DURATION 232 0.0107
427 HAIR TEXTURE ABNORMAL 143 0.0107
428 BONE PAIN 623 0.0106
429 ANXIETY 3024 0.0106
430 POLYURIA 87 0.0106
431 TOOTHACHE 192 0.0106
432 HAEMOLYTIC ANAEMIA 95 0.0106
433 ABDOMINAL PAIN 2466 0.0106
434 DYSURIA 390 0.0106
435 PHOTOPHOBIA 199 0.0106
436 HYPOTENSION 2118 0.0105
437 BURSITIS 128 0.0105
438 OBESITY 168 0.0105
439 OEDEMA PERIPHERAL 1285 0.0105
440 FLUID RETENTION 536 0.0105
441 CHOLECYSTECTOMY 120 0.0105
442 BLOOD CALCIUM INCREASED 92 0.0105
443 PULMONARY ARTERIAL HYPERTENSION 152 0.0105
444 HEART RATE IRREGULAR 237 0.0105
445 DELIRIUM 364 0.0105
446 PERIPHERAL SWELLING 1615 0.0105
447 URINARY INCONTINENCE 310 0.0105
448 JOINT INJURY 223 0.0104
449 VOMITING 4908 0.0104
450 MUSCLE STRAIN 90 0.0104
451 LABORATORY TEST ABNORMAL 307 0.0104
452 SPINAL OPERATION 128 0.0104
453 THYROID DISORDER 160 0.0104
454 CARDIAC FAILURE CONGESTIVE 833 0.0104
455 HYPOTHYROIDISM 331 0.0104
456 PYREXIA 3586 0.0104
457 PETECHIAE 108 0.0103
458 TRANSIENT ISCHAEMIC ATTACK 349 0.0103
459 TOOTH FRACTURE 114 0.0103
460 MIDDLE INSOMNIA 193 0.0103
461 BLOOD PRESSURE INCREASED 1579 0.0103
462 INJURY 725 0.0103
463 STAPHYLOCOCCAL INFECTION 340 0.0103
464 FACIAL PAIN 92 0.0103
465 EXOSTOSIS 94 0.0103
466 PRESYNCOPE 250 0.0103
467 ACUTE MYOCARDIAL INFARCTION 303 0.0103
468 PYELONEPHRITIS 89 0.0103
469 DRY MOUTH 832 0.0102
470 GROIN PAIN 90 0.0102
471 DYSPNOEA 5799 0.0102
472 NAUSEA 8074 0.0102
473 MYOCARDIAL ISCHAEMIA 116 0.0102
474 HEPATOMEGALY 100 0.0102
475 PERICARDIAL EFFUSION 235 0.0102
476 SCIATICA 162 0.0102
477 PHARYNGITIS 126 0.0101
478 INTESTINAL OBSTRUCTION 382 0.0101
479 SUBDURAL HAEMATOMA 145 0.0101
480 STEVENS-JOHNSON SYNDROME 225 0.0101
481 ALTERED STATE OF CONSCIOUSNESS 219 0.0101
482 THIRST 180 0.0101
483 PHARYNGITIS STREPTOCOCCAL 109 0.0101
484 INTERNATIONAL NORMALISED RATIO INCREASED 287 0.0101
485 DRUG EFFECT LESS THAN EXPECTED 149 0.0100
486 RHINITIS 81 0.0100
487 HYPERCALCAEMIA 124 0.0100
488 BLOOD TEST ABNORMAL 141 0.0100
489 HERNIA 194 0.0100
490 EYE INFECTION 113 0.0100
491 BLOOD THYROID STIMULATING HORMONE INCREASED 92 0.0100
492 WEIGHT DECREASED 2788 0.0100
493 EYE DISCHARGE 103 0.0099
494 PRODUCT USE COMPLAINT 156 0.0099
495 BLOOD PRESSURE FLUCTUATION 237 0.0099
496 WHEEZING 585 0.0099
497 INITIAL INSOMNIA 101 0.0098
498 ARTHRITIS 773 0.0098
499 HYPOAESTHESIA ORAL 148 0.0098
500 MUSCLE TIGHTNESS 159 0.0098
501 SKIN INFECTION 110 0.0098
502 THROMBOCYTOPENIA 1096 0.0098
503 LACRIMATION INCREASED 296 0.0098
504 IMMUNODEFICIENCY 146 0.0098
505 FATIGUE 7613 0.0098
506 GASTROINTESTINAL HAEMORRHAGE 817 0.0098
507 SWELLING FACE 636 0.0098
508 HAEMATURIA 334 0.0097
509 BODY TEMPERATURE DECREASED 96 0.0097
510 HEPATIC ENCEPHALOPATHY 91 0.0097
511 KIDNEY INFECTION 191 0.0097
512 ESCHERICHIA INFECTION 80 0.0097
513 FACE OEDEMA 164 0.0097
514 SWELLING 907 0.0097
515 SPINAL FRACTURE 194 0.0097
516 ANGIOEDEMA 428 0.0097
517 BRAIN OEDEMA 122 0.0096
518 BACK DISORDER 157 0.0096
519 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 225 0.0096
520 LOCALISED INFECTION 233 0.0096
521 DEPRESSION 2192 0.0096
522 HYPERGLYCAEMIA 351 0.0096
523 PULMONARY THROMBOSIS 105 0.0096
524 ASTHENIA 3618 0.0096
525 HEAD INJURY 304 0.0096
526 DEEP VEIN THROMBOSIS 623 0.0096
527 HAEMATEMESIS 243 0.0096
528 SHOCK HAEMORRHAGIC 78 0.0096
529 BLADDER DISORDER 95 0.0096
530 SHOCK 220 0.0096
531 C-REACTIVE PROTEIN INCREASED 348 0.0096
532 METASTASES TO LIVER 168 0.0095
533 BODY TEMPERATURE INCREASED 195 0.0095
534 PALPITATIONS 1119 0.0095
535 FULL BLOOD COUNT ABNORMAL 101 0.0095
536 HIP FRACTURE 307 0.0095
537 LETHARGY 549 0.0095
538 CARDIOMYOPATHY 141 0.0095
539 BLOOD PRESSURE SYSTOLIC INCREASED 186 0.0095
540 MIGRAINE 908 0.0095
541 FEELING HOT 582 0.0095
542 PROTEINURIA 180 0.0095
543 MASS 132 0.0094
544 ORTHOSTATIC HYPOTENSION 164 0.0094
545 ACUTE CORONARY SYNDROME 78 0.0094
546 HYPERTENSION 1994 0.0094
547 MUSCULAR WEAKNESS 1068 0.0094
548 PERIPHERAL COLDNESS 129 0.0094
549 RESPIRATORY DISORDER 281 0.0094
550 DIZZINESS 4677 0.0094
551 COMPLICATION ASSOCIATED WITH DEVICE 136 0.0094
552 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 159 0.0094
553 RECTAL HAEMORRHAGE 402 0.0093
554 CYANOSIS 147 0.0093
555 ANAPHYLACTIC SHOCK 241 0.0093
556 BLOOD TRIGLYCERIDES INCREASED 165 0.0093
557 URINARY RETENTION 311 0.0093
558 TOOTH DISORDER 207 0.0093
559 POLLAKIURIA 388 0.0093
560 FEELING COLD 258 0.0093
561 PRODUCT DOSE OMISSION ISSUE 2722 0.0092
562 PANCREATITIS ACUTE 208 0.0092
563 ASTHMA 1045 0.0092
564 CONTUSION 890 0.0092
565 GASTROINTESTINAL DISORDER 828 0.0092
566 BALANCE DISORDER 796 0.0092
567 HEMIPARESIS 156 0.0092
568 EYE SWELLING 342 0.0092
569 NERVE INJURY 102 0.0092
570 SCAR 157 0.0092
571 TOOTH EXTRACTION 114 0.0092
572 ABNORMAL FAECES 75 0.0091
573 SNEEZING 205 0.0091
574 FALL 3042 0.0091
575 METASTASES TO BONE 150 0.0091
576 HEART RATE DECREASED 320 0.0091
577 HEAD DISCOMFORT 161 0.0091
578 HYPOAESTHESIA 1361 0.0091
579 RASH PRURITIC 492 0.0091
580 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 436 0.0091
581 CYTOPENIA 111 0.0091
582 THERAPY INTERRUPTED 647 0.0090
583 LIMB DISCOMFORT 280 0.0090
584 COORDINATION ABNORMAL 126 0.0090
585 DYSSTASIA 263 0.0090
586 ANGINA PECTORIS 258 0.0090
587 INTESTINAL PERFORATION 101 0.0090
588 DYSGEUSIA 666 0.0090
589 HERPES ZOSTER 515 0.0090
590 HAEMORRHAGE INTRACRANIAL 134 0.0090
591 MADAROSIS 104 0.0090
592 INFLUENZA 999 0.0089
593 DIALYSIS 127 0.0089
594 FIBROMYALGIA 217 0.0089
595 PRURITUS 3427 0.0089
596 HOT FLUSH 671 0.0089
597 HEADACHE 5569 0.0089
598 TREMOR 1473 0.0089
599 LYMPHADENOPATHY 314 0.0089
600 MUSCLE SPASMS 1627 0.0089
601 PANIC ATTACK 323 0.0089
602 PULMONARY EMBOLISM 841 0.0088
603 BLOOD URINE PRESENT 168 0.0088
604 AUTOIMMUNE DISORDER 86 0.0088
605 PURPURA 78 0.0088
606 APHONIA 123 0.0088
607 HYPERSENSITIVITY 1635 0.0088
608 FACIAL PARALYSIS 75 0.0088
609 BLOOD CREATINE PHOSPHOKINASE INCREASED 253 0.0088
610 GAIT INABILITY 293 0.0088
611 PLASMA CELL MYELOMA 342 0.0088
612 HALLUCINATION, VISUAL 185 0.0088
613 POST PROCEDURAL HAEMORRHAGE 102 0.0088
614 MUSCLE ATROPHY 111 0.0088
615 FUNGAL INFECTION 291 0.0087
616 GINGIVAL BLEEDING 119 0.0087
617 FEELING JITTERY 166 0.0087
618 DISORIENTATION 345 0.0087
619 CARDIO-RESPIRATORY ARREST 364 0.0087
620 DISEASE PROGRESSION 1028 0.0087
621 EYE IRRITATION 499 0.0087
622 METASTASES TO LUNG 100 0.0086
623 THERAPY CHANGE 85 0.0086
624 TINNITUS 397 0.0086
625 CHROMATURIA 195 0.0086
626 CEREBRAL HAEMORRHAGE 308 0.0086
627 LUNG DISORDER 421 0.0086
628 NIGHT SWEATS 276 0.0086
629 THERAPY NON-RESPONDER 383 0.0085
630 FEAR 229 0.0085
631 JAUNDICE 229 0.0085
632 SKIN DISCOLOURATION 391 0.0085
633 SALIVARY HYPERSECRETION 85 0.0085
634 SPEECH DISORDER 445 0.0085
635 ARTHRALGIA 3530 0.0085
636 CONFUSIONAL STATE 1372 0.0085
637 MYOSITIS 76 0.0085
638 LIVER FUNCTION TEST INCREASED 181 0.0084
639 AGEUSIA 210 0.0084
640 THROMBOSIS 677 0.0084
641 HALLUCINATION 633 0.0084
642 COLON CANCER 125 0.0084
643 CYST 104 0.0084
644 BLISTER 470 0.0084
645 MELAENA 184 0.0084
646 PRODUCT USE IN UNAPPROVED INDICATION 2072 0.0084
647 PAIN IN EXTREMITY 2461 0.0083
648 INSOMNIA 2224 0.0083
649 NASOPHARYNGITIS 1537 0.0083
650 BURNING SENSATION 584 0.0083
651 RASH MACULAR 291 0.0083
652 POOR QUALITY SLEEP 179 0.0083
653 PANCREATITIS 439 0.0083
654 MYALGIA 1411 0.0083
655 RHABDOMYOLYSIS 346 0.0083
656 HYPERHIDROSIS 1063 0.0082
657 SKIN DISORDER 275 0.0082
658 APPENDICITIS 77 0.0082
659 INFECTION 1191 0.0082
660 CATARACT 490 0.0082
661 CHOKING 160 0.0082
662 BRONCHOSPASM 117 0.0082
663 CYTOMEGALOVIRUS INFECTION 136 0.0082
664 DIABETES MELLITUS 623 0.0082
665 DISCOMFORT 498 0.0082
666 PAIN 5012 0.0082
667 DYSARTHRIA 307 0.0081
668 HEPATIC FAILURE 245 0.0081
669 BRADYCARDIA 431 0.0081
670 RASH 3540 0.0081
671 LOWER LIMB FRACTURE 156 0.0081
672 SLEEP DISORDER 573 0.0081
673 WOUND INFECTION 88 0.0080
674 SYNCOPE 803 0.0080
675 HAEMATOMA 207 0.0080
676 GASTRIC DISORDER 274 0.0080
677 SURGERY 468 0.0080
678 DELUSION 124 0.0080
679 CARDIAC ARREST 659 0.0080
680 METABOLIC ACIDOSIS 255 0.0080
681 DISEASE RECURRENCE 379 0.0080
682 DEVICE OCCLUSION 112 0.0080
683 LEUKAEMIA 75 0.0079
684 EYE PRURITUS 267 0.0079
685 BLOOD COUNT ABNORMAL 120 0.0079
686 DEPRESSED LEVEL OF CONSCIOUSNESS 313 0.0079
687 METASTASES TO CENTRAL NERVOUS SYSTEM 102 0.0079
688 ELECTROCARDIOGRAM QT PROLONGED 282 0.0078
689 UNEVALUABLE EVENT 593 0.0078
690 GAIT DISTURBANCE 1496 0.0078
691 SEROTONIN SYNDROME 150 0.0078
692 BONE DENSITY DECREASED 244 0.0078
693 TYPE 2 DIABETES MELLITUS 262 0.0078
694 APHASIA 235 0.0078
695 SPINAL PAIN 91 0.0078
696 SKIN LESION 213 0.0078
697 DEMENTIA 217 0.0078
698 JOINT DISLOCATION 82 0.0077
699 BLOOD CHOLESTEROL INCREASED 361 0.0077
700 ORAL HERPES 151 0.0077
701 PARAESTHESIA 1217 0.0077
702 OSTEONECROSIS OF JAW 191 0.0077
703 EMOTIONAL DISTRESS 934 0.0077
704 DERMATITIS 161 0.0077
705 ABSCESS 122 0.0076
706 SEIZURE 882 0.0076
707 VISION BLURRED 1046 0.0076
708 PULMONARY FIBROSIS 146 0.0076
709 COLD SWEAT 134 0.0076
710 MOUTH ULCERATION 160 0.0076
711 IMPAIRED HEALING 249 0.0076
712 MUSCULOSKELETAL PAIN 396 0.0076
713 SKIN HAEMORRHAGE 112 0.0075
714 TENDONITIS 117 0.0075
715 WOUND 211 0.0075
716 CARDIAC FAILURE 604 0.0075
717 HAEMATOCHEZIA 415 0.0075
718 NEUTROPENIA 1021 0.0075
719 PHOTOSENSITIVITY REACTION 124 0.0075
720 HEPATIC CIRRHOSIS 141 0.0075
721 ATAXIA 89 0.0075
722 CONJUNCTIVITIS 139 0.0075
723 RESTLESSNESS 273 0.0075
724 HEPATIC ENZYME INCREASED 507 0.0074
725 GLAUCOMA 143 0.0074
726 SKIN FISSURES 145 0.0074
727 CARDIOGENIC SHOCK 106 0.0074
728 SOMNOLENCE 1485 0.0074
729 FEELING ABNORMAL 1763 0.0073
730 SLUGGISHNESS 75 0.0073
731 VERTIGO 446 0.0073
732 BASAL CELL CARCINOMA 114 0.0073
733 SCRATCH 77 0.0073
734 LIVER FUNCTION TEST ABNORMAL 212 0.0073
735 CONDITION AGGRAVATED 2198 0.0072
736 FOOT DEFORMITY 80 0.0072
737 ALOPECIA 1416 0.0072
738 EJECTION FRACTION DECREASED 112 0.0072
739 PARALYSIS 103 0.0072
740 OBSTRUCTIVE AIRWAYS DISORDER 80 0.0072
741 DRUG LEVEL INCREASED 119 0.0072
742 AMNESIA 467 0.0072
743 LOSS OF CONSCIOUSNESS 919 0.0072
744 DIPLOPIA 186 0.0072
745 TOOTH LOSS 148 0.0071
746 MALIGNANT NEOPLASM PROGRESSION 731 0.0071
747 DYSKINESIA 290 0.0071
748 ERYTHEMA 1465 0.0071
749 NODULE 93 0.0071
750 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1284 0.0071
751 MACULAR DEGENERATION 85 0.0071
752 THERAPY CESSATION 364 0.0071
753 BEDRIDDEN 93 0.0071
754 RASH ERYTHEMATOUS 337 0.0070
755 PALLOR 190 0.0070
756 UPPER LIMB FRACTURE 139 0.0070
757 RED BLOOD CELL SEDIMENTATION RATE INCREASED 77 0.0070
758 PHARYNGEAL OEDEMA 107 0.0069
759 OCULAR HYPERAEMIA 330 0.0069
760 GASTRIC HAEMORRHAGE 80 0.0069
761 MEMORY IMPAIRMENT 954 0.0069
762 DRUG INTERACTION 1096 0.0069
763 IMMUNE SYSTEM DISORDER 91 0.0069
764 WEIGHT INCREASED 1545 0.0069
765 RESPIRATORY ARREST 190 0.0069
766 FEMUR FRACTURE 213 0.0069
767 ACUTE MYELOID LEUKAEMIA 107 0.0069
768 COGNITIVE DISORDER 320 0.0068
769 DEAFNESS 179 0.0068
770 LEUKOPENIA 342 0.0068
771 MYOCLONUS 81 0.0068
772 DRUG-INDUCED LIVER INJURY 213 0.0068
773 ECZEMA 354 0.0068
774 MALAISE 2966 0.0068
775 DERMATITIS ALLERGIC 85 0.0068
776 DEPRESSED MOOD 357 0.0067
777 JOINT STIFFNESS 177 0.0067
778 OFF LABEL USE 5906 0.0067
779 PROCEDURAL PAIN 187 0.0067
780 JOINT RANGE OF MOTION DECREASED 90 0.0067
781 CARDIAC DISORDER 627 0.0067
782 SCAB 76 0.0067
783 NERVOUSNESS 348 0.0067
784 KNEE ARTHROPLASTY 140 0.0066
785 INCREASED APPETITE 127 0.0066
786 ACCIDENTAL OVERDOSE 243 0.0066
787 ROAD TRAFFIC ACCIDENT 277 0.0066
788 GLOSSODYNIA 148 0.0066
789 LYMPHOPENIA 93 0.0066
790 PRESCRIBED UNDERDOSE 131 0.0066
791 ADVERSE REACTION 87 0.0066
792 HOSPITALISATION 1008 0.0066
793 MENTAL DISORDER 284 0.0065
794 TRANSAMINASES INCREASED 145 0.0065
795 RASH PAPULAR 146 0.0065
796 CONVULSION 372 0.0065
797 PRODUCT AVAILABILITY ISSUE 148 0.0065
798 PRODUCT ADMINISTRATION ERROR 131 0.0065
799 HYPOGLYCAEMIA 314 0.0065
800 DISABILITY 128 0.0065
801 INTENTIONAL PRODUCT USE ISSUE 567 0.0065
802 HUNGER 90 0.0065
803 AGRANULOCYTOSIS 120 0.0064
804 ARRHYTHMIA 305 0.0064
805 NEOPLASM 74 0.0064
806 GASTRIC CANCER 163 0.0064
807 MUSCLE TWITCHING 148 0.0064
808 JOINT SWELLING 771 0.0064
809 ACUTE HEPATIC FAILURE 87 0.0064
810 MYELODYSPLASTIC SYNDROME 92 0.0064
811 MOBILITY DECREASED 456 0.0063
812 HIP ARTHROPLASTY 97 0.0063
813 INJECTION SITE RASH 194 0.0063
814 PROSTATIC SPECIFIC ANTIGEN INCREASED 87 0.0063
815 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 108 0.0063
816 INFLAMMATION 325 0.0063
817 FREQUENT BOWEL MOVEMENTS 170 0.0063
818 ABDOMINAL PAIN LOWER 159 0.0063
819 NEOPLASM PROGRESSION 217 0.0062
820 PERITONITIS 129 0.0062
821 AGITATION 457 0.0062
822 PRODUCT TASTE ABNORMAL 84 0.0062
823 RASH MACULO-PAPULAR 138 0.0062
824 PELVIC PAIN 112 0.0062
825 MUSCULOSKELETAL STIFFNESS 539 0.0061
826 TREATMENT NONCOMPLIANCE 335 0.0061
827 BONE MARROW FAILURE 124 0.0061
828 BLOOD GLUCOSE DECREASED 292 0.0061
829 SKIN EXFOLIATION 513 0.0061
830 IRRITABILITY 364 0.0060
831 CRYING 219 0.0060
832 PRESCRIBED OVERDOSE 116 0.0060
833 NEUROTOXICITY 105 0.0060
834 CEREBROVASCULAR ACCIDENT 1015 0.0060
835 ARTHROPATHY 333 0.0060
836 FRACTURE 113 0.0060
837 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 327 0.0060
838 GLYCOSYLATED HAEMOGLOBIN INCREASED 150 0.0059
839 HYPERTHYROIDISM 86 0.0059
840 EMOTIONAL DISORDER 183 0.0059
841 PRODUCT USE ISSUE 1115 0.0059
842 INFLUENZA LIKE ILLNESS 486 0.0059
843 HAEMORRHAGE 617 0.0059
844 LACTIC ACIDOSIS 191 0.0059
845 DRUG TOXICITY 80 0.0059
846 RASH GENERALISED 152 0.0059
847 MULTIPLE ORGAN DYSFUNCTION SYNDROME 166 0.0059
848 THINKING ABNORMAL 109 0.0058
849 THERAPY PARTIAL RESPONDER 91 0.0058
850 DIABETES MELLITUS INADEQUATE CONTROL 103 0.0058
851 INJECTION SITE SWELLING 445 0.0058
852 DRY SKIN 775 0.0058
853 BONE LOSS 87 0.0058
854 EXPIRED PRODUCT ADMINISTERED 192 0.0058
855 MOOD ALTERED 157 0.0058
856 THERAPEUTIC RESPONSE DECREASED 348 0.0057
857 HYPOKINESIA 83 0.0057
858 HYPOACUSIS 246 0.0057
859 EXPOSURE VIA SKIN CONTACT 148 0.0057
860 INCORRECT DRUG ADMINISTRATION DURATION 160 0.0057
861 EYE DISORDER 186 0.0057
862 THERAPEUTIC RESPONSE SHORTENED 187 0.0056
863 MOVEMENT DISORDER 181 0.0056
864 LYMPHOMA 87 0.0056
865 EOSINOPHILIA 98 0.0056
866 PARANOIA 96 0.0056
867 LOCAL SWELLING 97 0.0056
868 CONTRAINDICATED PRODUCT ADMINISTERED 168 0.0055
869 NIGHTMARE 192 0.0055
870 PRODUCT PRESCRIBING ISSUE 120 0.0055
871 SEDATION 144 0.0055
872 DRUG INTOLERANCE 531 0.0055
873 DIABETIC KETOACIDOSIS 132 0.0055
874 SKIN CANCER 118 0.0055
875 BLINDNESS UNILATERAL 77 0.0055
876 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 388 0.0054
877 PRODUCT PHYSICAL ISSUE 110 0.0054
878 ADVERSE DRUG REACTION 487 0.0054
879 DISTURBANCE IN ATTENTION 291 0.0054
880 VISUAL IMPAIRMENT 665 0.0054
881 INJECTION SITE REACTION 368 0.0053
882 MYOCARDIAL INFARCTION 932 0.0053
883 SKIN REACTION 75 0.0053
884 MUSCULOSKELETAL DISORDER 101 0.0053
885 INJECTION SITE PRURITUS 355 0.0053
886 DERMATITIS ATOPIC 279 0.0053
887 ACTIVITIES OF DAILY LIVING IMPAIRED 104 0.0052
888 IMPAIRED WORK ABILITY 112 0.0052
889 PRURITUS GENERALISED 113 0.0052
890 OSTEONECROSIS 170 0.0052
891 ABNORMAL DREAMS 142 0.0051
892 DRUG INEFFECTIVE 6760 0.0051
893 ILL-DEFINED DISORDER 311 0.0051
894 SENSORY DISTURBANCE 82 0.0051
895 HEPATITIS 130 0.0051
896 DEVICE FAILURE 77 0.0051
897 NEOPLASM MALIGNANT 334 0.0050
898 ABNORMAL BEHAVIOUR 197 0.0050
899 HALLUCINATION, AUDITORY 79 0.0050
900 INJECTION SITE URTICARIA 121 0.0049
901 NERVOUS SYSTEM DISORDER 153 0.0049
902 THERAPEUTIC PRODUCT EFFECT DECREASED 219 0.0049
903 SICKLE CELL ANAEMIA WITH CRISIS 77 0.0049
904 INJECTION SITE ERYTHEMA 600 0.0048
905 MENTAL IMPAIRMENT 117 0.0048
906 INJECTION SITE BRUISING 383 0.0048
907 RHEUMATOID ARTHRITIS 545 0.0048
908 GENERALISED TONIC-CLONIC SEIZURE 79 0.0048
909 GENERAL PHYSICAL HEALTH DETERIORATION 550 0.0047
910 INCORRECT DOSE ADMINISTERED 1073 0.0047
911 NEEDLE ISSUE 136 0.0047
912 DEATH 3987 0.0046
913 BLOOD GLUCOSE INCREASED 864 0.0046
914 CARDIOVASCULAR DISORDER 116 0.0046
915 NO ADVERSE EVENT 815 0.0045
916 MANIA 74 0.0045
917 SUICIDAL IDEATION 410 0.0045
918 PSORIATIC ARTHROPATHY 181 0.0045
919 BLOOD GLUCOSE ABNORMAL 82 0.0044
920 PRODUCT PRESCRIBING ERROR 105 0.0044
921 SYSTEMIC LUPUS ERYTHEMATOSUS 156 0.0044
922 MEDICATION ERROR 242 0.0043
923 MULTIPLE SCLEROSIS 208 0.0043
924 PRODUCT DOSE OMISSION 280 0.0043
925 ADVERSE EVENT 395 0.0043
926 PRODUCT SUBSTITUTION ISSUE 244 0.0042
927 EXTRA DOSE ADMINISTERED 171 0.0042
928 DEVICE DISLOCATION 183 0.0042
929 AGGRESSION 209 0.0042
930 ABASIA 103 0.0042
931 ANGER 140 0.0041
932 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 106 0.0041
933 BLINDNESS 167 0.0041
934 PRODUCT DISPENSING ERROR 89 0.0041
935 PAIN OF SKIN 109 0.0040
936 INJECTION SITE PAIN 1238 0.0040
937 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 813 0.0040
938 UNDERDOSE 292 0.0040
939 MULTIPLE SCLEROSIS RELAPSE 274 0.0040
940 INTENTIONAL PRODUCT MISUSE 345 0.0039
941 MOOD SWINGS 124 0.0039
942 PSYCHOTIC DISORDER 113 0.0038
943 DEVICE ISSUE 343 0.0038
944 DYSTONIA 74 0.0038
945 PANCREATIC CARCINOMA 110 0.0038
946 MATERNAL EXPOSURE DURING PREGNANCY 336 0.0038
947 TARDIVE DYSKINESIA 106 0.0038
948 INJECTION SITE WARMTH 77 0.0037
949 VISUAL ACUITY REDUCED 123 0.0037
950 COLITIS ULCERATIVE 163 0.0036
951 LUNG NEOPLASM MALIGNANT 147 0.0036
952 ERECTILE DYSFUNCTION 91 0.0035
953 EPILEPSY 108 0.0035
954 LOWER RESPIRATORY TRACT INFECTION 159 0.0035
955 LIVER INJURY 85 0.0035
956 COMA 162 0.0034
957 DEVICE MALFUNCTION 233 0.0033
958 VAGINAL HAEMORRHAGE 143 0.0033
959 INJECTION SITE MASS 120 0.0032
960 DRUG EFFECT DECREASED 174 0.0032
961 DEVICE LEAKAGE 140 0.0032
962 PSORIASIS 414 0.0032
963 WRONG TECHNIQUE IN DRUG USAGE PROCESS 115 0.0032
964 DRUG ADMINISTRATION ERROR 96 0.0031
965 WITHDRAWAL SYNDROME 130 0.0031
966 PHARMACEUTICAL PRODUCT COMPLAINT 78 0.0030
967 DRUG DOSE OMISSION 494 0.0030
968 PRODUCT QUALITY ISSUE 405 0.0030
969 SKIN BURNING SENSATION 213 0.0030
970 INJECTION SITE HAEMORRHAGE 234 0.0029
971 OVERDOSE 628 0.0029
972 ACNE 216 0.0028
973 DRUG EFFECT INCOMPLETE 102 0.0028
974 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 197 0.0028
975 RENAL CANCER 130 0.0027
976 ACCIDENTAL EXPOSURE TO PRODUCT 274 0.0027
977 ABORTION SPONTANEOUS 105 0.0026
978 TOXICITY TO VARIOUS AGENTS 441 0.0026
979 SKIN IRRITATION 117 0.0026
980 SUICIDE ATTEMPT 145 0.0024
981 COMPLETED SUICIDE 194 0.0023
982 DEVICE USE ERROR 80 0.0023
983 DEVICE BREAKAGE 90 0.0022
984 PROSTATE CANCER 174 0.0022
985 TREATMENT FAILURE 177 0.0021
986 PRODUCT STORAGE ERROR 183 0.0021
987 BREAST CANCER 190 0.0020
988 BLADDER CANCER 120 0.0020
989 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 90 0.0019
990 DRUG WITHDRAWAL SYNDROME 158 0.0018
991 FOETAL EXPOSURE DURING PREGNANCY 130 0.0016
992 DEVICE DIFFICULT TO USE 90 0.0014
993 DRUG DOSE OMISSION BY DEVICE 83 0.0011
994 DRUG DEPENDENCE 150 0.0009